Zacks Investment Research
21 Jul 2026, 16:50 UTC · 10w ago
Verdict
Headline leans bullish. We score MRSH +0.60 across four claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.60strongly bullish
What the story claims
4 claims · scored −1 bearish … +1 bullish
Marsh & McLennan reported Q2 2026 adjusted EPS of $2.96, beating the Zacks Consensus Estimate by 2.8%.
More positive than 66% of claims this week
Consolidated revenues rose 6.2% year over year to $7.4 billion, exceeding consensus estimates by 2%.
Continue reading
5 related stories
More positive than 78% of ticker scores this week
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 54% of claims this week
The Guy Carpenter unit's revenues fell 2% year over year to $664 million, missing the consensus mark by 4.4%.
More negative than 68% of claims this week
Total operating expenses increased 7% year over year to $5.5 billion, driven primarily by higher compensation and benefits costs.
So whatRising operational costs and wage pressure can compress margins and weigh on long-term profitability.
More negative than 62% of claims this week
Which stocks this story touches
More positive than 78% of ticker scores this week
The company reported adjusted EPS and revenue that surpassed consensus estimates with year-over-year growth.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−6.4%
Price is moving against the score
$170.42 vs $182.10 close before publication (Jul 20) · not market-adjusted
MRSH chart →
